NovoCure Ltd (NVCR)

69.10 +5.76  +9.09% NASDAQ Apr 6, 20:00 Delayed 2m USD

NovoCure Cash from Investing (TTM):

-51.67M for Dec. 31, 2019
View 4,000+ financial data types
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2014. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 -51.67M
Sept. 30, 2019 -6.70M
June 30, 2019 -5.531M
March 31, 2019 -4.625M
Dec. 31, 2018 -5.493M
Sept. 30, 2018 -5.65M
June 30, 2018 -6.398M
March 31, 2018 -6.142M
Dec. 31, 2017 8.628M
Sept. 30, 2017 7.164M
June 30, 2017 4.503M
March 31, 2017 -1.536M
Dec. 31, 2016 13.00M
Sept. 30, 2016 -109.63M
June 30, 2016 -77.85M
March 31, 2016 -109.13M
Dec. 31, 2015 -115.30M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Abbott Laboratories -1.815B
Amgen Inc 5.709B
Immunogen Inc -0.533M

Cash from Investing (TTM) Range, Past 5 Years

Minimum -115.30M Dec 2015
Maximum 13.00M Dec 2016
Average -27.79M



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.